The document discusses issues Indian pharmaceutical companies face with regulatory authorities like the US FDA and initiatives to help them comply with FDA standards. It explains that the FDA wants to know if drugs are safe, effective, have responsible oversight, and believable results. Companies must meet Good Manufacturing Practices (GMP) standards for approval through continuous efforts. A startup called FDAsmart provides training to help companies meet FDA requirements through both in-person and online sessions to assist their work while not disrupting operations. The conclusion states FDAsmart is working well to improve quality for companies seeking FDA recognition, which benefits the Indian pharma sector that has funds and staff but requires guidance.